Suchergebnisse - "Gelber, R D"

PubPharm (32)

1

Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer : original article

enthalten in: Annals of oncology | 28 November 2022

von Geyer, C. | Garber, J. | Gelber, R. | +73

2

Tailoring therapies-improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015

enthalten in: Annals of oncology | 2015

von Coates, A. | Winer, E. | Goldhirsch, A. | +5

3

Chemotherapy benefit for 'ER-positive' breast cancer and contamination of nonluminal subtypes—waiting for TAILORx and RxPONDER

enthalten in: Annals of oncology | 2015

von Sun, Z. | Prat, A. | Cheang, M. | +2

4

Outcomes of special histotypes of breast cancer after adjuvant endocrine therapy with letrozole or tamoxifen in the monotherapy cohort of the BIG 1-98 trial

enthalten in: Annals of oncology | 2015

von Munzone, E. | Giobbie-Hurder, A. | Gusterson, B. | +12

5

Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013

enthalten in: Annals of oncology | 2013

von Goldhirsch, A. | Winer, E. | Coates, A. | +56

6

Prognosis of medullary breast cancer: analysis of 13 International Breast Cancer Study Group (IBCSG) trials

enthalten in: Annals of oncology | 2012

von Huober, J. | Gelber, S. | Goldhirsch, A. | +7

7

Patterns and risk factors for locoregional failures after mastectomy for breast cancer: an International Breast Cancer Study Group report

enthalten in: Annals of oncology | 2012

von Karlsson, P. | Cole, B. | Chua, B. | +12

8

Prognostic and predictive role of ESR1 status for postmenopausal patients with endocrine-responsive early breast cancer in the Danish cohort of the BIG 1-98 trial

enthalten in: Annals of oncology | 2012

von Ejlertsen, B. | Aldridge, J. | Nielsen, K. | +10

9

Which patients benefit most from adjuvant aromatase inhibitors? Results using a composite measure of prognostic risk in the BIG 1-98 randomized trial

enthalten in: Annals of oncology | 2011

von Viale, G. | Regan, M. | Dell'Orto, P. | +17

10

Long-term results of International Breast Cancer Study Group Trial VIII: adjuvant chemotherapy plus goserelin compared with either therapy alone for premenopausal patients with node-negative breast cancer

enthalten in: Annals of oncology | 2011

von Karlsson, P. | Sun, Z. | Braun, D. | +14